Taro Pharmaceutical Industries Ltd
NYSE:TARO
Taro Pharmaceutical Industries Ltd
Accounts Payable
Taro Pharmaceutical Industries Ltd
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Accounts Payable
$44.7m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Accounts Payable
$2.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-3%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Accounts Payable
₪133.6m
|
CAGR 3-Years
93%
|
CAGR 5-Years
107%
|
CAGR 10-Years
51%
|
Mediwound Ltd
NASDAQ:MDWD
|
Accounts Payable
$5.5m
|
CAGR 3-Years
23%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Accounts Payable
₪105.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
13%
|
CAGR 10-Years
3%
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Accounts Payable
₪6.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Taro Pharmaceutical Industries Ltd's Accounts Payable?
Accounts Payable
44.7m
USD
Based on the financial report for Mar 31, 2024, Taro Pharmaceutical Industries Ltd's Accounts Payable amounts to 44.7m USD.
What is Taro Pharmaceutical Industries Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
8%
Over the last year, the Accounts Payable growth was -51%. The average annual Accounts Payable growth rates for Taro Pharmaceutical Industries Ltd have been -10% over the past three years , 5% over the past five years , and 8% over the past ten years .